Wikidata

(Q65379176)

English

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

clinical trial

In more languages

Statements

title
AMR PH GL 2007 CL001 Phase 3 A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients With Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Czech Republic
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
September 2007
0 references
end time
May 2011
0 references
number of participants
637
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65379176&oldid=2182553055"